Phostal / Stallergenes - LARVOL DELTA

Allergy immunotherapies for allergic rhinitis: systematic review and assessment of evolving quality. (PubMed, Eur Ann Allergy Clin Immunol) - "17 of 44 unique RCTs (38.6%) (sample size range: 18-1,501 subjects) were subcutaneous grass immunotherapy trials and 27 (61.4%) were sublingual grass immunotherapy trials (Allergovit, 5 trials; Alutard, 8; Grazax, 13; Oralair, 6; Staloral, 8; Pollinex, 2; Phostal and Purethal, 1 each). Conclusions. When as-sessing grass AIT, it is important to focus not only on endpoints but also on the quality of evidence."

Journal • Review • Allergic Rhinitis • Allergy • Asthma • Immunology • Respiratory Diseases